Literature DB >> 2776628

Screening for mouse retinal degenerations. I. Correlation of indirect ophthalmoscopy, electroretinograms, and histology.

J R Heckenlively1, J V Winston, T H Roderick.   

Abstract

Mice with hereditary retinal degeneration have provided excellent models for human disease of the biochemical and physiological events occurring in retinal degeneration. Since a number of mouse models are available for other human conditions, more mouse retinal degenerations would be expected to be known; however, finding new models has proved difficult since the search has usually involved laborious histologic screening. We applied the clinical technique of indirect ophthalmoscopy to screen mice for retinal degeneration and then used electroretinography and histology to determine whether true retinal degeneration was present. A Dawson-Trick-Litzkow microfiber corneal electrode was used to record the electroretinogram since the fiber does not occlude the pupil in these small eyes. Normal control values were developed. As an example of the success of the technique, one strain, lethal spot (ls) on indirect ophthalmoscopy appeared to have a retinal degeneration, but these mice had a normal electroretinogram indicating a primary optic atrophy. Likewise, one ls heterozygote that was tested as a control animal and was not suspected of having a retinal degeneration had an abnormal electroretinogram and peripheral retinal degeneration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2776628     DOI: 10.1007/BF00170972

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  9 in total

1.  Two types of retinal degeneration in cerebellar mutant mice.

Authors:  R J Mullen; M LaVail
Journal:  Nature       Date:  1975-12-11       Impact factor: 49.962

2.  The electroretinogram in advanced open-angle glaucoma.

Authors:  D T Fazio; J R Heckenlively; D A Martin; R E Christensen
Journal:  Doc Ophthalmol       Date:  1986-06-16       Impact factor: 2.379

3.  Changes in the electroretinogram in patients with optic nerve lesions.

Authors:  M Feinsod; H Rowe; E Auerbach
Journal:  Doc Ophthalmol       Date:  1971-05-14       Impact factor: 2.379

4.  Report of the Committee on Comparative Mapping.

Authors:  P A Lalley; V A McKusick
Journal:  Cytogenet Cell Genet       Date:  1985

5.  Lengths of chromosomal segments conserved since divergence of man and mouse.

Authors:  J H Nadeau; B A Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

6.  Lysosomes and melanin granules of the retinal pigment epithelium in a mouse model of the Chediak-Higashi syndrome.

Authors:  W G Robison; T Kuwabara; D G Cogan
Journal:  Invest Ophthalmol       Date:  1975-04

7.  Cyclic nucleotide content and phosphodiesterase activity in the rds mouse (020/A) retina.

Authors:  S Sanyal; R Fletcher; Y P Liu; G Aguirre; G Chader
Journal:  Exp Eye Res       Date:  1984-03       Impact factor: 3.467

8.  Screening for mouse retinal degenerations. II. Molossinus MOLC and MOLD strains.

Authors:  J V Winston; J R Heckenlively; T H Roderick
Journal:  Doc Ophthalmol       Date:  1989-03       Impact factor: 2.379

9.  Improved electrode for electroretinography.

Authors:  W W Dawson; G L Trick; C A Litzkow
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-09       Impact factor: 4.799

  9 in total
  10 in total

1.  A simple and stable d.c.electrode for ocular electrophysiology.

Authors:  G Niemeyer; N Kueng
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

Review 2.  Genetic factors of age-related macular degeneration.

Authors:  Jingsheng Tuo; Christine M Bojanowski; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2004-03       Impact factor: 21.198

3.  A deletion in a photoreceptor-specific nuclear receptor mRNA causes retinal degeneration in the rd7 mouse.

Authors:  N B Akhmedov; N I Piriev; B Chang; A L Rapoport; N L Hawes; P M Nishina; S Nusinowitz; J R Heckenlively; T H Roderick; C A Kozak; M Danciger; M T Davisson; D B Farber
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Mouse eye enucleation for remote high-throughput phenotyping.

Authors:  Vinit B Mahajan; Jessica M Skeie; Amir H Assefnia; Maryann Mahajan; Stephen H Tsang
Journal:  J Vis Exp       Date:  2011-11-19       Impact factor: 1.355

5.  Fierce: a new mouse deletion of Nr2e1; violent behaviour and ocular abnormalities are background-dependent.

Authors:  Kelly A Young; Melissa L Berry; Connie L Mahaffey; Jennifer R Saionz; Norman L Hawes; Bo Chang; Qing Yin Zheng; Richard S Smith; Roderick T Bronson; Randy J Nelson; Elizabeth M Simpson
Journal:  Behav Brain Res       Date:  2002-05-14       Impact factor: 3.332

6.  Mouse model for Usher syndrome: linkage mapping suggests homology to Usher type I reported at human chromosome 11p15.

Authors:  J R Heckenlively; B Chang; L C Erway; C Peng; N L Hawes; G S Hageman; T H Roderick
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Screening for mouse retinal degenerations. II. Molossinus MOLC and MOLD strains.

Authors:  J V Winston; J R Heckenlively; T H Roderick
Journal:  Doc Ophthalmol       Date:  1989-03       Impact factor: 2.379

8.  Comparisons of the amplitude size and the reproducibility of three different electrodes to record the corneal flash electroretinogram in rodents.

Authors:  A U Bayer; T Mittag; P Cook; S E Brodie; S M Podos; K P Maag
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 1.854

9.  Early Loss of Vision Results in Extensive Reorganization of Plasticity-Related Receptors and Alterations in Hippocampal Function That Extend Through Adulthood.

Authors:  Mirko Feldmann; Daniela Beckmann; Ulf T Eysel; Denise Manahan-Vaughan
Journal:  Cereb Cortex       Date:  2019-02-01       Impact factor: 5.357

Review 10.  Electrophysiological analysis of visual function in mutant mice.

Authors:  Neal S Peachey; Sherry L Ball
Journal:  Doc Ophthalmol       Date:  2003-07       Impact factor: 1.854

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.